ORION®

Our goal is to help the profoundly blind regain visual perception.

The Orion® Visual Cortical Prosthesis System (“Orion”) is a novel medical device system that leverages our neurostimulation technology. It is intended to deliver meaningful perception of motion and light. As the next generation of the Argus® Retinal Prosthesis System, our first commercial product and the world’s first FDA-approved system for artificial vision, Orion is built on over 20 years of proven breakthrough neuroscience.

Orion-modified.jpg

APPLICATION

Orion has the potential to treat nearly all forms of profound blindness, including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma.

82,000+

PROFOUNDLY BLIND AMERICANS COULD POTENTIALLY BENEFIT FROM ORION¹

Bringing together artificial intelligence, virtual reality, and the Orion & Argus II visual prostheses. The Argus II is no longer available, and Orion is an investigative device not approved by the FDA. Source: YouTube.

Transmitting visual information to the brain.

HOW IT WORKS

  1. Through cranial surgery, a microelectronic implant is applied to the surface of the brain’s visual cortex.

  2. Our data processing unit converts images captured by a miniature video camera mounted on glasses into a series of small electrical pulses.

  3. These electrical pulses are wirelessly transmitted to the implant and brain, bypassing the diseased or injured visual pathway and providing the perception of light patterns.

Not an actual Orion patient

Clinical Development

We conducted an Early Feasibility Study at UCLA and the Baylor College of Medicine to explore the clinical potential of Orion. With 5 years of data in hand, we plan to discuss the continued regulatory pathway with the FDA.

[1] Based on a company-sponsored US market study by Fletcher Spaght, Inc.